• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

CRISPR Therapeutics Has Soared in Just a Few Weeks - What to Do Now

This is a time to nail down profits.
By BRUCE KAMICH
Jan 14, 2021 | 01:22 PM EST
Stocks quotes in this article: CRSP

We wrote about CRISPR Therapeutics (CRSP) on January 6 and said traders should "Continue to hold longs risking to $149 now. Our price targets are $200 and $230 for now." CRSP is now trading around $215 so I think another look at the stock is warranted and perhaps a change in strategy.  

 
In this updated daily Japanese candlestick chart of CRSP, below, we can see some weakening of the indicators. Trading volume has expanded this month as prices have increased. Normally this is considered a good thing but with heady gains in the broad averages we might be seeing too many recent longs with a high cost. A small pullback in the stock could inflict pain on the recent buyers.
 
Prices are above the rising 50-day and the rising 200-day moving average lines, but now prices are really extended above both of these measures. The On-Balance-Volume (OBV) line has climbed higher and tells us that buyers of CRSP have been aggressive.
 
The 12-day price momentum study in the lower panel shows lower highs from December into January. Lower highs mean that the pace of the rise has slowed. A slowing pace of acceleration can mean that some traders are resisting the advance or taking profits into strength. This is a heads up that the gains may not be sustainable. 
 
 
In this weekly Japanese candlestick chart of CRSP, below, we can see the recent overbought reading from the slow stochastic indicator. We can see that prices are extended - $100 above the rising 40-week moving average line. The OBV is positive.  
 
 
In this weekly line chart of CRSP, below, we can see an extreme condition with the Bollinger bands - very wide. 
 
 
In this daily Point and Figure chart of CRSP, below, we see a new price target of $318 but also that there is not much in the way of nearby support (volume by price bars). A price retreat could be sharp.  
 
 
Bottom line strategy: CRSP has soared in a short period of time to trade in the middle of our two price targets - $200 and $230. Momentum has slowed and my years of experience and the hairs on my neck tell me this is a time to nail down profits . 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Biotechnology

More from Investing

Specific Stocks Appear Solid but Upward Momentum Can't Yet Be Trusted

James "Rev Shark" DePorre
May 19, 2022 4:29 PM EDT

I remain convinced that we can't begin to talk about a bottom in the indexes until the S&P 500 is in a technical bear market.

Is This the Time to Buy Costco?

Bruce Kamich
May 19, 2022 3:05 PM EDT

Buy a falling knife? No, but this one's intriguing.

Stay on Track While Interpreting the Dow Theory and CSX Corp.

Bruce Kamich
May 19, 2022 2:26 PM EDT

Some investors may be asking whether we're seeing another 'nail in the coffin' of the secular bull market as several transport names get downgraded. Let's not ... go off the rails.

TJX Cos. Is Ignoring the Market's Downdraft

Bruce Kamich
May 19, 2022 1:25 PM EDT

Does this strength have staying power?

These ETFs Will Meet You in the After-Hours Club

Mark Abssy
May 19, 2022 12:30 PM EDT

Let's check three funds that are set to buy the close and sell the open.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • 03:07 PM EDT PAUL PRICE

    Why Is Walmart Down Big Today?

    Besides its poor earnings report Walmart was way...
  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login